Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

20.52
-2.9800-12.68%
Post-market: 20.600.0801+0.39%19:59 EST
Volume:7.20M
Turnover:150.55M
Market Cap:1.98B
PE:-3.52
High:23.17
Open:21.54
Low:19.61
Close:23.50
52wk High:46.27
52wk Low:18.41
Shares:96.48M
Float Shares:92.79M
Volume Ratio:4.05
T/O Rate:7.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8316
EPS(LYR):-5.8316
ROE:-412.99%
ROA:-24.92%
PB:216.15
PE(LYR):-3.52

Loading ...

Ultragenyx Faces Securities Class Action Over Misleading Study Claims

Reuters
·
Yesterday

Is Ultragenyx Pharmaceutical (RARE) Mispriced After Steep Multi‑Year Share Price Declines?

Simply Wall St.
·
Yesterday

Ultragenyx Faces Securities Class Action Over Alleged Misleading Statements

Reuters
·
Feb 15

Ultragenyx Faces Class Action Lawsuit Over Alleged Misleading Statements on Setrusumab Trials

Reuters
·
Feb 14

Why Is Ultragenyx Stock Sinking Friday?

Benzinga
·
Feb 14

Ultragenyx Pharmaceutical Faces Lawsuit Following Clinical Trial Disclosures

TIPRANKS
·
Feb 14

Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Feb 13

Ultragenyx price target lowered to $61 from $71 at Goldman Sachs

TIPRANKS
·
Feb 13

Stock Track | Ultragenyx Pharmaceutical Plummets 8.34% Intraday Following Multiple Analyst Price Target Cuts

Stock Track
·
Feb 13

Stock Track | Ultragenyx Pharmaceutical Plunges 7.28% in Pre-market After Multiple Analyst Price Target Cuts

Stock Track
·
Feb 13

Ultragenyx Pharmaceutical Inc : TD Cowen Cuts Target Price to $49 From $75

THOMSON REUTERS
·
Feb 13

RBC Capital Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Feb 13

Truist Cuts Price Target on Ultragenyx Pharmaceutical to $76 From $90, Keeps Buy Rating

MT Newswires Live
·
Feb 13

Ultragenyx Pharmaceutical Inc : Leerink Partners Cuts Target Price to $60 From $70

THOMSON REUTERS
·
Feb 13

Stock Track | Ultragenyx Pharmaceutical Plunges 5.32% After-Hours on Earnings Miss, Weak Guidance and Restructuring Plan

Stock Track
·
Feb 13

Ultragenyx Cuts 10% of Workforce, Targets Profitability in 2027

Dow Jones
·
Feb 13

Earnings Flash (RARE) Ultragenyx Pharmaceutical Posts Q4 Revenue $207M, vs. FactSet Est of $198.6M

MT Newswires Live
·
Feb 13

Ultragenyx Q4 revenue rises 25% amid restructuring

Reuters
·
Feb 13

Ultragenyx Pharmaceutical Q4 EPS $(1.29) Misses $(1.14) Estimate, Sales $207.000M Beat $196.971M Estimate

Benzinga
·
Feb 13

Ultragenyx posts Q4 2025 product sales of USD 102 million, up 42 percent

Reuters
·
Feb 13